Search Results - Chouaid C

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents by Vergnenègre A, Borget I, Chouaid C

Connect to this object online.

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review by Chouaïd C, Crequit P, Borget I, Vergnenegre A

Connect to this object online.

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer by Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S

Connect to this object online.

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France by Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S

Connect to this object online.

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France by Taipale K, Winfree KB, Boye M, Basson M, Sleilaty G, Eaton J, Evans R, Chouaid C

Connect to this object online.

Cost analysis of adverse events associated with non-small cell lung cancer management in France by Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E

Connect to this object online.

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe by Walleser S, Ray J, Bischoff H, Vergnenègre A, Rosery H, Chouaid C, Heigener D, de Castro Carpeño J, Tiseo M, Walzer S

Connect to this object online.